CYNTHIA L. FLOWERS, M.B.A.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LISATA THERAPEUTICS, INC.

Filing Date Source Excerpt
2023-05-01 The Audit Committee consists of three directors: Ms. Henson (Chair), Ms. Flowers and Mr. Klosk. Each member of the committee is independent applying the definition of independence under the listing standards of Nasdaq and SEC regulations. The Audit Committee met five times during the year. Ms. Henson, Ms. Flowers and Mr. Klosk each qualify as an “audit committee financial expert” as defined by Item 407(d)(5)(ii) of Regulation S-K. ... Our Compensation Committee consists of three directors: Mr. Klosk (Chair), Dr. Brown and Ms. Henson. ... Our Nominating and Governance Committee consists of four directors: Dr. Gregory Brown (Chair), Dr. Azab, Ms. Flowers and Dr. Ruoslahti. ... The following table sets forth information on all compensation to Lisata's directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2022. ... Cynthia L. Flowers, M.B.A. $52,500 Fees Earned in Cash, $59,999 Stock Awards, $112,499 Total Compensation.
2024-04-29 Ms. Flowers was appointed to our board of directors in November 2018. She is currently CEO of OMEZA Holdings, Inc., an advanced wound care company.

Data sourced from SEC filings. Last updated: 2025-08-30